Meredith Pelster

Efficacy and Safety of Adagrasib plus Cetuximab in Patients with KRASG12C-Mutated Metastatic Colorectal Cancer

Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation

Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C